logo
State hands out first round of dairy modernization grants

State hands out first round of dairy modernization grants

Yahoo02-06-2025
LOWVILLE, N.Y. (WWTI) – Dairy farms are hoping to get a shot in the arm from the first round of funding from New York State to help with modernization.
Governor Kathy Hochul announced on Monday nearly $21.6 million has been awarded to 103 farms across the state through the Dairy Modernization Grant Program to support New York's dairy industry.
Need for milk once Chobani expands to Rome seems promising to family dairy farms
The awards were announced this morning at a special event at Glory Days Farm, a 120-cow dairy farm in Lowville in Lewis County. Dignitaries such as Agriculture Commissioner Richard Ball, Lewis County Manager Tim Hunt and Lowville Mayor Dan Salmon were on hand for the announcement.
Our aspiration is for our farm and farms like ours to remain viable for future generations. The Dairy Modernization Grant Program gives farms like ours the opportunity to progress and innovate, and continue being the lifeblood of our communities. This program encourages the adoption of efficient technology that improves food safety with more consideration to environmental impacts, securing the future of dairy in New York.
The Beyer Family, owners of Glory Days Farm in Lowville
Here's a breakdown of funding by region:
Capital Region: nine farms were awarded a total of nearly $1.8 million.
Central New York: 18 farms were awarded a total of more than $3.9 million.
Finger Lakes: 20 farms were awarded a total of more than $4.3 million.
Mid-Hudson: One farm was awarded more than $147,000.
Mohawk Valley: 11 farms were awarded a total of more than $2.1 million.
North Country: 15 farms were awarded a total of more than $3.3 million.
Southern Tier: 13 farms were awarded a total of nearly $2.6 million.
Western New York: 13 farms were awarded a total of more than $2.7 million.
Here is the list of farms in Jefferson, Lewis and St. Lawrence counties that will be part of the first round of grants:
CTS Dairy (Jefferson)
Locust Hill Dairy LLC (Jefferson)
North Harbor Dairy, LLC (Jefferson)
Sheland Farms, LLC (Jefferson)
Celtic Acres, LLC (Lewis)
Glory Days Farm (Lewis)
Irish Settlement Farm (Lewis)
Moserdale Dairy (Lewis)
Murrock Farms LLC (Lewis)
Silvery Falls Farms LLC (Lewis)
J & J FARMS (St. Lawrence)
River Breeze Dairy LLC (St. Lawrence)
Royal J. Acres LLC. (St. Lawrence)
Stauffer Farms LLC (St. Lawrence)
The grant program awarded eligible applicants for projects to expand on-farm milk storage capacity, improve the transportation and storage of milk, and strengthen the dairy industry. The program supports the needs of dairy farmers by facilitating the installation of critical technological and infrastructural improvements that will improve dairy supply chain efficiency and avoid the need for raw milk dumping during emergency events.
NYS has roughly 3,000 dairy farms that produce over 16 billion pounds of milk annually, making New York the nation's fifth-largest dairy state.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Liberty All-Star® Equity Fund July 2025 Monthly Update
Liberty All-Star® Equity Fund July 2025 Monthly Update

Business Wire

timean hour ago

  • Business Wire

Liberty All-Star® Equity Fund July 2025 Monthly Update

BOSTON--(BUSINESS WIRE)--Below is the July 2025 Monthly Update for the Liberty All-Star Equity Fund (NYSE: USA). Liberty All-Star Equity Fund Ticker: USA Monthly Update, July 2025 Investment Approach: Fund Style: Large-Cap Core Fund Strategy: Combines three value-style and two growth-style investment managers. Those selected demonstrate a consistent investment philosophy, decision making process, continuity of key people and above-average long-term results compared to managers with similar styles. Investment Managers: Value Managers: Aristotle Capital Management, LLC Fiduciary Management, Inc. Pzena Investment Management, LLC Growth Managers: Sustainable Growth Advisers, LP TCW Investment Management Company Top 20 Holdings at Month-End: (38.8% of equity portfolio) 1 Microsoft Corp. 5.1% 2 NVIDIA Corp. 4.9% 3 Amazon, Inc. 3.0% 4 Alphabet, Inc. 2.7% 5 Capital One Financial Corp. 2.3% 6 Meta Platforms, Inc. 2.1% 7 Visa, Inc. 1.8% 8 ServiceNow, Inc. 1.7% 9 Charles Schwab Corp. 1.5% 10 Synopsys, Inc. 1.5% 11 Fresenius Medical Care AG 1.4% 12 S&P Global, Inc. 1.4% 13 Ferguson Enterprises, Inc. 1.3% 14 Sony Group Corp. 1.3% 15 Wells Fargo & Co. 1.2% 16 CVS Health Corp. 1.2% 17 Booking Holdings, Inc. 1.2% 18 Aramark 1.1% 19 Broadcom Inc. 1.1% 20 Parker-Hannifin Corp. 1.0% Holdings are subject to change. Expand Monthly Performance: Performance NAV Market Price Discount Beginning of month value $7.03 $6.81 -3.1% Distributions (Ex-Date July 18 th) $0.18 $0.18 End of month value $6.84 $6.52 -4.7% Performance for month -0.02% -1.62% Performance year-to-date 5.91% 0.96% Expand Net Assets at Month-End ($millions): Total $2,017.3 Equities $2,025.1 Percent Invested 100.4% Expand Sector Breakdown* (% of equity portfolio): New Holdings: Eaton Corp. PLC NIKE, Inc. W.W. Grainger, Inc. Holdings Liquidated: ANSYS, Inc. Novo Nordisk A/S The net asset value (NAV) of a closed-end fund is the market value of the underlying investments (i.e., stocks and bonds) in the Fund's portfolio, minus liabilities, divided by the total number of Fund shares outstanding. However, the Fund also has a market price; the value at which it trades on an exchange. If the market price is above the NAV the Fund is trading at a premium. If the market price is below the NAV the Fund is trading at a discount. Performance returns for the Fund are total returns, which includes dividends, and are net of management fees and other Fund expenses. Returns are calculated assuming that a shareholder reinvested all distributions. Past performance cannot predict future investment results. Performance will fluctuate with changes in market conditions. Current performance may be lower or higher than the performance data shown. Performance information shown does not reflect the deduction of taxes that shareholders would pay on Fund distributions or the sale of Fund shares. Shareholders must be willing to tolerate significant fluctuations in the value of their investment. An investment in the Fund involves risk, including loss of principal. Sources of distributions to shareholders may include ordinary dividends, long-term capital gains and return of capital. The final determination of the source of all distributions in 2025 for tax reporting purposes will be made after year end. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund's investment experience during its fiscal year and may be subject to changes based on tax regulations. Based on current estimates a portion of the distributions consist of a return of capital. These estimates may not match the final tax characterization (for the full year's distributions) contained in shareholder 1099-DIV forms after the end of the year.

MediMergent Launches Pilot Program Deploying Virtual Human Advocates to Facilitate Community-Based Clinical Research
MediMergent Launches Pilot Program Deploying Virtual Human Advocates to Facilitate Community-Based Clinical Research

Business Wire

time11 hours ago

  • Business Wire

MediMergent Launches Pilot Program Deploying Virtual Human Advocates to Facilitate Community-Based Clinical Research

ROCKVILLE, Md.--(BUSINESS WIRE)-- MediMergent, LLC, the Real-World Evidence Company, announces the launch of its newest digital platform to enhance patient engagement and education. This AI-driven solution, utilized by pharma, providers, payers, and patients is facilitated by Virtual Human Advocates (VHA) designed to incorporate personalized facial, body, voice, and language preferences of the patient. The platform will be deployed in a pilot program to reduce the workload of study coordinators at community-based research centers. The VHA will assist in screening and recruiting patients and supporting follow-up strategies related to risk assessment, medication adherence, study compliance and retention, safety reporting, emotion detection, and monitoring study activities. The Program, launched in 10 community-based research centers across the US, will leverage point-of-care digital communication tools available in the practice's waiting and examination rooms. By using the 'wait time' in both locations, the VHA will engage the captive audience in conversations related to trials open for recruitment, roles and responsibilities of trial participants, inclusion criteria, and the overall value proposition of participating in a research trial. Sandra Garrett, Ph.D., the CEO of MediMergent states: 'At a time when more research programs are being directed towards community-based medical practices, the number of clinical trial staff has been significantly reduced. Without additional resources, practices are turning away research opportunities. Our VHAs provide intelligent and interactive methods for monitoring and tracking outcomes while communicating and supporting patient compliance and retention. The VHAs fill a critical gap by off-loading select time-consuming activities, thereby freeing up the study personnel to focus on clinical events.' About MediMergent: MediMergent, LLC, a Real-World Evidence Company, supports a suite of AI-driven digital applications for data collection, integration, and analytics deployed in pre- and post-approval research for drugs, biologics, and medical devices. With an emphasis on 'Voice of the Patient' data, including emotion detection, intent, attitudes, behaviors, cognition, and other biomarkers, MediMergent 's technologies can impact patients' Quality of Life, adherence, persistence, stress, anxiety, and other outcome measures. Under an extended public/private partnership with the FDA, MediMergent has commercialized three digital platforms including MediManager ™ for digital management of clinical trials, MediMentor ™ for enhanced patient engagement and education, and MediMetrics ™ a curated data base that integrates multiple sources of Real-World Data and proprietary analytics to generate Real-World Evidence.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store